Shabad Kriya for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Shabad Kriya for Health & Longevity

Created on 09/02/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A free bedtime meditation with a fixed breath pattern — short inhale, long hold, short exhale, silent phrase — for eleven to thirty-one minutes nightly. In adults with long-standing trouble falling asleep, a routine built around it beat sleep education, gains persisting past training. Two studies, one researcher with a stake in the practice. Everything beyond sleep is borrowed. (Full Review)

Protocol

Breath ratio
4:16:2
Inhale through the nose in four equal segments, hold for sixteen counts, exhale in two. Sa-Ta-Na-Ma repeated silently across the inhale and the hold, Wahe Guru across the exhale.
Duration
11–31 minutes
The clinical form. The traditional form offers eleven, fifteen, twenty-two, thirty-one or sixty-two minutes, with sixty-two reserved for experienced practitioners.
Best time of day
Immediately before bed
In the evening, immediately before bed, which is the point of the technique. Both trials permitted another time of day when the evening schedule made it impossible.
Time to effect
Sleep gains
8 weeks
Total sleep time rose progressively across the eight weeks rather than jumping early. A fair evaluation needs a full eight weeks; two weeks tells nothing.
Durability
6 months
Diary gains held at six months. Adherence beyond that was never recorded.
Decision point
Week 8
If time to fall asleep and the Insomnia Severity Index have not moved by week eight, escalation to cognitive behavioral therapy for insomnia rather than continued waiting.

Benefits

Contraindications
  • Pregnancy from the second trimester onward
  • Uncontrolled hypertension (resting pressure ≥180/110 mmHg)
  • Recent myocardial infarction (heart attack, <90 days) or unstable angina (chest pain at rest)
  • Untreated angle-closure glaucoma
  • Poorly controlled epilepsy (any seizure within the past 12 months)
  • Active psychosis, current mania, or acute suicidal crisis
  • Untreated moderate-to-severe obstructive sleep apnea (15 or more breathing pauses per hour)
    •
Key Interactions
  • Sedative-hypnotics (zolpidem, eszopiclone, temazepam): Caution
  • Antihypertensives (lisinopril, amlodipine, metoprolol): Caution
  • Beta-blockers (metoprolol, propranolol, bisoprolol): Monitor
  • Selective serotonin reuptake inhibitors (sertraline, escitalopram, fluoxetine): Monitor
  • Corticosteroids (prednisone, dexamethasone) and stimulants (methylphenidate, modafinil): Caution
  • Over-the-counter sleep aids (diphenhydramine, doxylamine, melatonin): Caution
  • Sedating supplements (valerian, magnesium glycinate, L-Theanine, ashwagandha, cannabidiol): Caution
  • Alcohol and evening caffeine: Caution
  • Cognitive behavioral therapy for insomnia and sleep restriction: Monitor for conflict
  • Positive airway pressure therapy: Monitor
    •

Risk & Side Effects

  • High:
  • Medium: Meditation-related anxiety, low mood and cognitive anomalies
  • Low: Lightheadedness and air hunger during the 16-count hold; displacement of cognitive behavioral therapy for insomnia; practice burden and dropout
  • Speculative: Destabilizing spontaneous experiences
    •

Monitoring

Marker Target Why
Time to fall asleep (sleep diary) Under 20 minutes The primary endpoint the practice targets
Sleep efficiency (sleep diary) 85–92% Captures continuity, not just onset
Insomnia Severity Index 0–7 (no clinical insomnia) Validated severity scale, comparable to trial data
Pittsburgh Sleep Quality Index 5 or below Covers the past month, smoothing diary noise
Nocturnal resting heart rate (wearable) Within 3 bpm of personal best 14-night baseline Objective marker of overnight autonomic state
Nocturnal heart rate variability (wearable) No established target — a sustained rise above the personal 14-night baseline Indexes vagus-nerve activity, the proposed mechanism
Resting blood pressure Under 120/80 mmHg Downstream target of both slow breathing and better sleep
High-sensitivity C-reactive protein Under 1.0 mg/L Low-grade inflammation rises with chronic sleep loss
Hemoglobin A1c 4.8–5.4% Sleep restriction degrades glucose control within days
Morning cortisol 10–15 µg/dL at 30 minutes after waking Indexes the overnight stress-hormone axis
Epworth Sleepiness Scale 0–7 Distinguishes better sleep from merely more time in bed

Cadence: Baseline testing begins two weeks before the first session. The sleep diary and the Insomnia Severity Index repeat at week 4 and week 8, the wearable metrics run continuously, and the blood draw and blood pressure repeat at 6 months and then every 6 to 12 months.

Qualitative Assessment

  • Ease of returning to sleep after a night waking, rather than the number of wakings
  • Presence or absence of racing thoughts in the ten minutes after lights-out
  • Morning refreshment on waking, independent of total hours slept
  • Afternoon energy stability, particularly the size of the post-lunch dip
  • Cognitive clarity and word-finding in the first two hours awake
  • Whether the breath rhythm has begun to feel automatic, which the tradition predicts after several months
  • Willingness to practise on a difficult evening, which is the most honest adherence signal available
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.